Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. ALVO
ALVO logo

ALVO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ALVO News

Alvotech Q4 2025 Earnings Call Highlights

Mar 19 2026seekingalpha

Alvotech Reports Significant Growth in 2025 Financials

Mar 19 2026NASDAQ.COM

Alvotech Q4 Revenue Exceeds Expectations

Mar 19 2026seekingalpha

Alvotech to Release Q4 and Full Year 2025 Results

Mar 04 2026Newsfilter

Alvotech Under Investigation for Securities Law Violations

Feb 24 2026Globenewswire

Alvotech Increases Share Capital by $125,000

Feb 11 2026Yahoo Finance

Alvotech Under Investigation Following 34% Stock Drop After FDA CRL

Feb 09 2026Globenewswire

Alvotech Faces Securities Claims Investigation

Feb 09 2026PRnewswire

Alvotech Faces Securities Claims Investigation by Rosen Law Firm

Feb 05 2026Globenewswire

Alvotech's AVT80 Biosimilar Study Achieves Success

Feb 05 2026seekingalpha

Alvotech Reports Positive Results for AVT80 Study

Feb 05 2026stocktwits

Alvotech Reports Positive Results for AVT80 Clinical Study

Feb 05 2026Newsfilter

Alvotech Faces Securities Claims Investigation

Feb 03 2026Globenewswire

Alvotech Enters Supply Agreements with Sandoz for Biosimilars

Feb 02 2026NASDAQ.COM

Alvotech Enters Supply Agreements with Sandoz for Biosimilars

Feb 02 2026Newsfilter

Alvotech Faces Securities Claims Investigation by Rosen Law Firm

Jan 30 2026Globenewswire